Item 9 Labs Corp. INLB
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -42.75% | -78.88% | -135.69% | -185.56% | -- |
| Total Depreciation and Amortization | -19.40% | 0.02% | 24.60% | 52.48% | -- |
| Total Amortization of Deferred Charges | -46.80% | -42.31% | -30.24% | -2.14% | -- |
| Total Other Non-Cash Items | 210.70% | 281.28% | 456.76% | 478.91% | -- |
| Change in Net Operating Assets | 33.16% | 53.81% | 5,657.50% | 373.18% | -- |
| Cash from Operations | 0.74% | -222.14% | 23.20% | 62.36% | -- |
| Capital Expenditure | 49.02% | 76.83% | 56.51% | -93.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 98.53% | 52.59% | 85.99% | 91.80% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.01% | 102.52% | -265.98% | -14,002.00% | -- |
| Cash from Investing | 61.97% | 79.42% | 10.52% | -31.71% | -- |
| Total Debt Issued | -53.37% | 34.85% | 133.17% | 264.96% | -- |
| Total Debt Repaid | 57.85% | 23.21% | 30.09% | 14.84% | -- |
| Issuance of Common Stock | -82.66% | -44.07% | -91.28% | -95.07% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.20% | -3.38% | -53.63% | -149.00% | -- |
| Cash from Financing | -54.57% | 89.64% | -1.81% | -46.39% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -278.31% | 99.90% | 90.43% | -199.93% | -- |